BSEBoard Meeting6 Aug 2026 · 6 Aug 2026, 05:35 pm

Omkar Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve Unaudited Financial result ....

Omkar Pharmachem Ltd · 532167

✦ AI SummaryResults

Omkar Pharmachem Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 to consider and approve Unaudited Financial result for the quarter ended on June 30, 2026 along with Limited Review Report thereof.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Omkar Pharmachem Ltd - 532167 - Board Meeting Intimation for Intimation Of The Board Meeting Of The Company Under Regulation 29(1)(A) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Attachments (1)

📄

092cc3e4-42c9-4ca8-a641-eb426a4c871f.pdf

pdf

Download →
View document text
30 Ombkayr Phavmachem 4. Date: 06.08.2026 BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai-400001 Sub: Intimation of the Board Meeting of the Company Under Regulation 29(1)(A) of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 Company Scrip Code: 532167 Dear Sir(s), Pursuant to Regulations 29(1)(a) of SEBI (LODR) Regulations 2015 notice is hereby given that a meeting of Board of Directors of Omkar Pharmachem Limited will be held on Thursday, 13" Day of August, 2026 at 03:30 P.M. at the registered office of the Company inter alia, to consider and approve: 1. Unaudited Financial result for the quarter ended on June 30, 2026 along with Limited Review Report thereof. Further, in continuation to our Intimation dated June 25, 2026 regarding closure of trading window for dealing in shares of the Company, we hereby inform you that pursuant to the Code of Conduct to Regulate, Monitor and Report Trading in Securities of the Company, the trading window for dealing in shares of the Company shall continue to remain closed till August 15, 2026, (inclusive) for all the Designated Persons of the Company and their Immediate Relatives. Thanking you, Yours faithfully, For Omkar Pharmachem Limited BHAWAN i dcov IS GOYA5L76Y w570 Bhawani S Goyal (Managing Director) DIN: 03255804 Address: Ward No-03, Nangal Chaudhry, Narnaul, Mahendragarh, Haryana-123023 Reg. Off.: 310, Wall Street-1, Near Gujarat College Cross Road, Ellisbridge Ahmedabad-380006, GJ, Ph.: 9711811163 CIN: L93000GJ1995PLC025276, Email: investors.opl@gmail.com, Website: www.omkarpharmachem.co.in